OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

Recombinant antibody production employs Chinese hamster ovary (CHO) cells due to their adaptability in expressing complex molecules. Improving these processes involves adjusting various factors, including cell line engineering, media formulation, and bioreactor environments. A key goal is to increase antibody production while reducing production co